Although there is evidence to support using serum BNP and NT-proBNP levels as adjunctive markers to define the progression of heart failure, limitations such as stratifying heterogeneous patient groups or effectively identifying those presenting with heart failure with preserved ejection fraction are persistently mentioned [16, 17]. The gene discussed is NPPB; the disease is heart failure.